A detailed history of Private Trust CO Na transactions in Biogen Inc. stock. As of the latest transaction made, Private Trust CO Na holds 958 shares of BIIB stock, worth $218,491. This represents 0.02% of its overall portfolio holdings.

Number of Shares
958
Previous 559 71.38%
Holding current value
$218,491
Previous $144,000 43.06%
% of portfolio
0.02%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$212.02 - $267.71 $84,595 - $106,816
399 Added 71.38%
958 $206,000
Q4 2023

Jan 24, 2024

SELL
$222.59 - $267.94 $7,790 - $9,377
-35 Reduced 5.89%
559 $144,000
Q3 2023

Oct 18, 2023

BUY
$253.3 - $285.89 $8,865 - $10,006
35 Added 6.26%
594 $152,000
Q2 2023

Jul 28, 2023

BUY
$275.25 - $318.06 $9,909 - $11,450
36 Added 6.88%
559 $159,000
Q1 2023

Apr 12, 2023

BUY
$256.56 - $292.34 $15,906 - $18,125
62 Added 13.45%
523 $145,000
Q4 2022

Jan 18, 2023

SELL
$252.44 - $306.72 $3,786 - $4,600
-15 Reduced 3.15%
461 $0
Q3 2022

Oct 17, 2022

SELL
$194.69 - $268.46 $1,362 - $1,879
-7 Reduced 1.45%
476 $127,000
Q2 2022

Sep 16, 2022

BUY
$187.54 - $223.02 $90,581 - $107,718
483 New
483 $99,000
Q1 2022

Apr 12, 2022

SELL
$193.77 - $244.14 $238,724 - $300,780
-1,232 Closed
0 $0
Q4 2021

Jan 10, 2022

SELL
$223.92 - $287.77 $20,376 - $26,187
-91 Reduced 6.88%
1,232 $295,000
Q3 2021

Oct 06, 2021

SELL
$282.99 - $369.05 $9,904 - $12,916
-35 Reduced 2.58%
1,323 $374,000
Q2 2021

Jul 07, 2021

SELL
$259.0 - $414.71 $78,218 - $125,242
-302 Reduced 18.19%
1,358 $470,000
Q1 2021

Apr 06, 2021

SELL
$242.95 - $284.63 $9,960 - $11,669
-41 Reduced 2.41%
1,660 $464,000
Q4 2020

Jan 05, 2021

SELL
$236.26 - $355.63 $49,378 - $74,326
-209 Reduced 10.94%
1,701 $416,000
Q3 2020

Oct 01, 2020

BUY
$264.77 - $305.71 $505,710 - $583,906
1,910 New
1,910 $541,000
Q2 2020

Jul 07, 2020

SELL
$258.66 - $342.55 $171,750 - $227,453
-664 Closed
0 $0
Q1 2020

Apr 07, 2020

BUY
$268.85 - $341.04 $178,516 - $226,450
664 New
664 $210,000
Q2 2019

Jul 02, 2019

SELL
$219.29 - $241.72 $347,355 - $382,884
-1,584 Closed
0 $0
Q1 2019

Apr 02, 2019

BUY
$216.71 - $338.96 $28,389 - $44,403
131 Added 9.02%
1,584 $0
Q4 2018

Jan 03, 2019

SELL
$278.5 - $352.75 $16,988 - $21,517
-61 Reduced 4.03%
1,453 $437,000
Q3 2018

Oct 09, 2018

BUY
$293.51 - $383.83 $15,262 - $19,959
52 Added 3.56%
1,514 $0
Q2 2018

Jul 03, 2018

BUY
$257.52 - $306.91 $14,678 - $17,493
57 Added 4.06%
1,462 $0
Q1 2018

Apr 03, 2018

BUY
$260.13 - $367.91 $27,573 - $38,998
106 Added 8.16%
1,405 $0
Q4 2017

Jan 16, 2018

BUY
$307.64 - $344.58 $155,050 - $173,668
504 Added 63.4%
1,299 $0
Q3 2017

Oct 12, 2017

BUY
$281.15 - $329.69 $223,514 - $262,103
795
795 $0

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.